Analysis of single nucleotide polymorphisms in chronic beryllium disease.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 14 12 2020
accepted: 22 03 2021
entrez: 17 4 2021
pubmed: 18 4 2021
medline: 20 11 2021
Statut: epublish

Résumé

Sarcoidosis and chronic beryllium disease (CBD) are phenocopies, however the latter one has a clear trigger factor that is beryllium exposure. This study analyses single nucleotide polymorphisms (SNPs) in a large cohort for beryllium-exposed persons. SNPs were chosen for their relevance in sarcoidosis. Even though one of largest cohorts of beryllium-exposed persons was analysed, no statistically relevant association between any SNP and CBD could be verified. Notably, some SNPs exhibit inverse OR for beryllium sensitization and CBD with nominally statistical significance, which allows hypothesizing about pathophysiological role of genes for the disease triggering and development.

Identifiants

pubmed: 33863318
doi: 10.1186/s12931-021-01691-2
pii: 10.1186/s12931-021-01691-2
pmc: PMC8051053
doi:

Substances chimiques

BTNL2 protein, human 0
Butyrophilins 0
DNA 9007-49-2
Beryllium OW5102UV6N

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Subventions

Organisme : Deutscher Forschungsgemeinschaft / German Research Foundation
ID : Mu692/7-1

Références

Semin Respir Crit Care Med. 2014 Jun;35(3):316-29
pubmed: 25007084
Curr Opin Pulm Med. 2016 Sep;22(5):476-83
pubmed: 27379969
Tissue Antigens. 2007 Dec;70(6):480-6
pubmed: 17927685
Semin Respir Crit Care Med. 2014 Jun;35(3):296-306
pubmed: 25007082
Nat Genet. 2008 Sep;40(9):1103-6
pubmed: 19165924
J Immunol. 2016 Jan 1;196(1):22-7
pubmed: 26685315
Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59
pubmed: 25398119
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 01;33(2):102-11
pubmed: 27537711

Auteurs

Björn C Frye (BC)

Department of Pneumology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Killianstrasse 5, 79106, Freiburg, Germany.

Karoline I Gaede (KI)

BioMaterial Bank Nord, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Parkallee 35, Germany.
Airway Research Center North, German Center for Lung Research (DZL), Wöhrendamm 80, 22927, Großhansdorf, Germany.

Cesare Saltini (C)

Department of Medicine, University of Florida, 1600 Archer Rd, Gainesville, 32610, FL, USA.

Milton D Rossman (MD)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, USA.

Dimitri S Monos (DS)

Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, USA.

Ken D Rosenman (KD)

Division of Occupational and Environmental Medicine, Department of Medicine, Michigan State University, East Lansing, MI, USA.

Christine R Schuler (CR)

Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA.

Ainsley Weston (A)

Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA.

Ralf Wegner (R)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Rainer Noth (R)

Institute for Clinical Molecular Biology, Christian-Albrechts University, Kiel, Germany.

Gernot Zissel (G)

Department of Pneumology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Killianstrasse 5, 79106, Freiburg, Germany.

Stefan Schreiber (S)

Institute for Clinical Molecular Biology, Christian-Albrechts University, Kiel, Germany.

Michael Nothnagel (M)

Department of Statistical Genetics and Bioinformatics, Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.
University Hospital Cologne, Cologne, Germany.

Joachim Müller-Quernheim (J)

Department of Pneumology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Killianstrasse 5, 79106, Freiburg, Germany. joachim.mueller-quernheim@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH